Clinical Trials Browser

Carcinoma, Intraductal, Noninfiltrating, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Phase NA Recruiting

82 enrolled

LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

NCT04323774 2025-12-12

AYA-RISE

Phase NA Active not recruiting

115 enrolled

Cancer Risk Syndrome

NCT06744595 2025-12-12

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Phase NA Enrolling by invitation

40 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04447703 2025-12-02

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Phase NA Completed

346 enrolled

Genitourinary

Prostatic Neoplasms

NCT05487846 2025-10-10

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Phase NA Recruiting

120 enrolled

Genitourinary

Prostatic Neoplasms

NCT03460483 2025-10-03

OPTEC

Phase NA Completed

1,001 enrolled

GastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT04316507 2020-10-23

Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients

Phase NA Unknown

100 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03075540 2019-12-12

Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer

Phase NA Completed

88 enrolled

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT01850654 2018-06-28

OCCPI

Phase NA Completed

3,470 enrolled

GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT01851109 2016-01-28

Prevention of Ovarian Cancer in Women Participating in Mammography

Phase NA Completed

458 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00165152 2012-08-09

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

Phase NA Completed

150 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Clinical Trials

VERDI

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

AYA-RISE

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

OPTEC

Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients

Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer

OCCPI

Prevention of Ovarian Cancer in Women Participating in Mammography

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing